Lead party: Cipla (EU) Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Cipla Maroc SA (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Morocco
Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity · Deal amount: US$8m · Equity stake: 0.151% · Implied EV: US$53.2m
Lead investor/buyer: Cipla (EU) Limited · Investors/buyers: Cipla (EU) Limited · Sellers: The Pharmaceutical Institute
Legal advisers: not identified in the source record.
Source: announced 13 September 2023. Original announcement: cipla.com.


